{
  "id": 8836118,
  "title": "Altis Labs, whose AI model analyzes CT scans taken during oncology trials and produces predictions tied to patient survival, has raised a $25M Series A (Natalie Breymeyer/Axios)",
  "url": "https://urgent.news/2026/09/21/altis-labs-whose-ai-model-analyzes-ct-scans-taken-during-oncology",
  "topic": "ai",
  "section": "AI",
  "published": "2026-09-21T04:05:32.000Z",
  "source": {
    "name": "Techmeme",
    "slug": "techmeme",
    "url": "https://www.axios.com/pro/biotech-deals/2026/09/17/altis-labs-series-a-ai-clinical-trial"
  },
  "original_language": "en",
  "account": null,
  "summary": "Altis Labs, an AI software company for drug development, raised a $25 million Series A, CEO Felix Baldauf-Lenschen tells Axios Pro.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Techmeme",
        "title": "Mithrl, which integrates its proprietary biomedical world model with the R&D systems of pharmaceutical companies, raised a $20M Series A led by Obvious Ventures (Natalie Breymeyer/Axios)",
        "url": "https://urgent.news/2026/09/21/mithrl-which-integrates-its-proprietary-biomedical-world-model-with",
        "published": "2026-09-21T01:40:01.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}